Premium Nahrungsergänzungsmittel | artgerecht

PACAP – Neuropeptide, Migraine & Function

PACAP (Pituitary Adenylate Cyclase-Activating Polypeptide) is an endogenous neuropeptide with key roles in the nervous and endocrine systems, notably involved in migraine attacks and the regulation of stress responses.

Regular tips about health Regular tips about health

Things worth knowing about "PACAP"

PACAP (Pituitary Adenylate Cyclase-Activating Polypeptide) is an endogenous neuropeptide with key roles in the nervous and endocrine systems, notably involved in migraine attacks and the regulation of stress responses.

What is PACAP?

PACAP (Pituitary Adenylate Cyclase-Activating Polypeptide) is an endogenous neuropeptide – a small protein molecule that acts as a chemical messenger in the nervous system. First isolated in 1989 from the ovine hypothalamus, it belongs to the secretin/glucagon superfamily of peptides. PACAP exists in two biologically active forms: PACAP-38 (38 amino acids) and PACAP-27 (27 amino acids). PACAP-38 is the predominant form found in the human body.

Distribution in the Body

PACAP is widely distributed throughout the human body and is found in particular in:

Central nervous system (brain and spinal cord)
Peripheral nervous system
Hypothalamus and pituitary gland
Adrenal medulla
Gastrointestinal tract
Reproductive organs
Immune cells

Mechanism of Action

PACAP exerts its effects by binding to specific cell surface receptors. Three receptor subtypes have been identified:

PAC1 receptor: binds PACAP exclusively with high affinity
VPAC1 receptor: binds both PACAP and the related peptide VIP (Vasoactive Intestinal Peptide)
VPAC2 receptor: also binds both PACAP and VIP

Upon receptor binding, PACAP primarily activates the cAMP signaling pathway (cyclic adenosine monophosphate), triggering a wide range of cellular responses including vasodilation, neuroprotection, and the release of additional signaling molecules.

Biological Functions

PACAP fulfills numerous important roles throughout the body:

Neurotransmitter and neuromodulator: Modulates the transmission of nerve signals
Neuroprotective effects: Protects nerve cells from programmed cell death (apoptosis) during injury or disease
Regulation of the stress response: Plays a key role in activating the stress axis (HPA axis) and the release of stress hormones such as cortisol
Vasodilation: Dilates blood vessels, particularly those in the brain
Regulation of sleep and circadian rhythms
Immunomodulation: Influences inflammatory responses
Hormone secretion: Stimulates the release of various pituitary hormones

PACAP and Migraine

One of the most intensively studied aspects of PACAP is its role in migraine. Research has demonstrated that intravenous infusion of PACAP-38 can trigger typical migraine attacks in patients with a history of migraine. Elevated plasma levels of PACAP-38 have been detected during spontaneous migraine attacks.

The vasodilatory effect of PACAP on cranial blood vessels and the activation of the trigeminovascular system (a key pain-processing network in the brain) are considered central mechanisms in migraine pathophysiology. This has positioned PACAP as a promising therapeutic target for new migraine treatments. Monoclonal antibodies targeting either the PAC1 receptor or PACAP itself are currently being investigated in clinical trials for migraine prevention.

PACAP and Psychiatric Disorders

Emerging research suggests that PACAP may also play a role in anxiety disorders, post-traumatic stress disorder (PTSD), and depression. Alterations in PACAP signaling have been linked to stress processing, particularly in women, which may partly explain the higher prevalence of PTSD in females.

PACAP in Medical Research

Due to its wide-ranging effects, PACAP is being actively investigated as a potential therapeutic agent for various conditions, including:

Neurodegenerative diseases (e.g., Parkinson's disease, Alzheimer's disease)
Stroke (neuroprotective effects)
Inflammatory bowel disease
Diabetes (influence on insulin secretion)
Migraine (receptor blockade as a therapeutic target)

References

Vaudry, D. et al. (2009): Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery of the Neuropeptide. Pharmacological Reviews, 61(3), 283–357. PubMed PMID: 19805477.
Ashina, M. et al. (2012): PACAP38 induces migraine-like attacks in patients with migraine without aura. Cephalalgia, 32(15), 1116–1123. PubMed PMID: 22906677.
Ressler, K.J. et al. (2011): Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature, 470(7335), 492–497. PubMed PMID: 21350482.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.